Back to search
Drug-resistant Neuropathic Pain
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Drug-resistant Neuropathic Pain trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Drug-resistant Neuropathic Pain trials you may qualify forNeuropathic pain is a public health problem with less than 50% of patients being relieved by drug treatments. Surgically implanted motor cortex stimulation rep…
The evaluation of neurosurgical outcomes varies from center to center, and the predictive factors that determine these outcomes are not fully known or shared. T…
The aim of this study is to evaluate, versus placebo, the analgesic efficacy of the opercular-insular cortex stimulation with Transcranial Direct Current Stimul…
Prevalence of neuropathic pain raise to 6.9 % in the general population and can reach more than 58 % for patients that carry a lesion of the spinal cord. This p…